Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal?

Introduction: Benzodiazepines (BZDs) are used in the management of anxiety and sleep disorders; however, chronic use is associated with tolerance and dependence. During withdrawal, symptoms of anxiety are often severe and problematic for patients and may lead to relapse or maintenance on low doses o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Alexander, MacDonald, Tim, Bennett, Kellie, Basso-Hulse, Gioiamia, Hulse, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573680/
https://www.ncbi.nlm.nih.gov/pubmed/36233814
http://dx.doi.org/10.3390/jcm11195948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573680/
https://www.ncbi.nlm.nih.gov/pubmed/36233814
http://dx.doi.org/10.3390/jcm11195948

Ejemplares similares